NASDAQ:ITRI - Itron Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $97.45
  • Forecasted Upside: 10.47 %
  • Number of Analysts: 12
  • Breakdown:
  • 1 Sell Ratings
  • 1 Hold Ratings
  • 10 Buy Ratings
  • 0 Strong Buy Ratings
$88.22
▼ -0.5 (-0.56%)
1 month | 3 months | 12 months
Get New Itron Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for ITRI and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for ITRI

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$97.45
▲ +10.47% Upside Potential
This price target is based on 12 analysts offering 12 month price targets for Itron in the last 3 months. The average price target is $97.45, with a high forecast of $140.00 and a low forecast of $56.00. The average price target represents a 10.47% upside from the last price of $88.22.
Buy
The current consensus among 12 investment analysts is to buy stock in Itron. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 12 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/27/2019
  • 0 strong buy ratings
  • 11 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/25/2020
  • 0 strong buy ratings
  • 9 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/24/2020
  • 0 strong buy ratings
  • 10 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/23/2020
  • 0 strong buy ratings
  • 9 buy ratings
  • 0 hold ratings
  • 1 sell ratings
10/21/2020
  • 0 strong buy ratings
  • 8 buy ratings
  • 0 hold ratings
  • 1 sell ratings
1/19/2021
  • 0 strong buy ratings
  • 8 buy ratings
  • 0 hold ratings
  • 1 sell ratings
3/20/2021
  • 0 strong buy ratings
  • 10 buy ratings
  • 1 hold ratings
  • 1 sell ratings
4/19/2021

Latest Recommendations

  • 0 strong buy ratings
  • 10 buy ratings
  • 1 hold ratings
  • 1 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
4/1/2021JPMorgan Chase & Co.Initiated CoverageOverweight$110.00Medium
i
4/1/2021Piper SandlerInitiated CoverageOverweight$120.00Medium
i
3/31/2021Morgan StanleyInitiated CoverageEqual Weight$90.00Medium
i
3/26/2021JPMorgan Chase & Co.Initiated CoverageOverweight$110.00High
i
3/26/2021Piper SandlerInitiated CoverageOverweight$120.00High
i
3/9/2021ArgusUpgradeHold ➝ Buy$140.00High
i
3/3/2021OppenheimerBoost Price TargetOutperform$75.00 ➝ $127.00Low
i
3/3/2021ArgusUpgradeHold ➝ Buy$140.00Low
i
2/25/2021OppenheimerBoost Price TargetPositive ➝ Outperform$75.00 ➝ $127.00Low
i
1/8/2021Raymond JamesDowngradeStrong-Buy ➝ Outperform$78.00 ➝ $110.00High
i
10/15/2020StephensInitiated CoverageOverweightMedium
i
9/28/2020Raymond JamesUpgradeOutperform ➝ Strong-Buy$78.00High
i
8/25/2020Wolfe ResearchInitiated CoverageUnderperform$56.00Medium
i
8/11/2020OppenheimerInitiated CoverageBuy$75.00Low
i
Rating by Noah Kaye at Oppenheimer Holdings Inc.
8/4/2020OppenheimerLower Price TargetOutperform$82.00 ➝ $75.00High
i
8/4/2020Raymond JamesLower Price TargetOutperform$82.00 ➝ $78.00High
i
6/26/2020OppenheimerLower Price TargetOutperform$90.00 ➝ $82.00High
i
6/18/2020Canaccord GenuityReiterated RatingBuyLow
i
5/26/2020Johnson RiceInitiated CoverageBuy$80.00High
i
5/15/2020OppenheimerReiterated RatingBuy$90.00Low
i
5/5/2020JMP SecuritiesLower Price TargetMarket Outperform$95.00 ➝ $80.00High
i
5/5/2020CowenLower Price TargetOutperform$88.50 ➝ $78.00High
i
5/5/2020Canaccord GenuityReiterated RatingBuy$81.00High
i
5/5/2020OppenheimerReiterated RatingBuy$90.00High
i
3/19/2020ArgusDowngradeBuy ➝ HoldHigh
i
2/26/2020StephensLower Price TargetEqual Weight$96.00 ➝ $83.00High
i
Rating by Robert McCarthy at Stephens
2/25/2020JMP SecuritiesReiterated RatingOutperform$95.00High
i
11/5/2019OppenheimerBoost Price Target$75.00 ➝ $90.00Low
i
11/5/2019Robert W. BairdBoost Price TargetOutperform$80.00 ➝ $86.00High
i
Rating by Ben Kallo at Robert W. Baird
10/21/2019Canaccord GenuityBoost Price TargetBuy$77.00 ➝ $87.00High
i
10/18/2019StephensSet Price TargetHold$83.00Low
i
Rating by Robert McCarthy at Stephens
10/1/2019Raymond JamesBoost Price TargetOutperform$75.00 ➝ $82.00High
i
9/18/2019Robert W. BairdReiterated RatingOutperform$70.00 ➝ $80.00High
i
8/20/2019Raymond JamesDowngradeStrong-Buy ➝ Outperform$75.00High
i
8/20/2019Credit Suisse GroupDowngradeOutperformHigh
i
8/16/2019ArgusUpgradeHold ➝ BuyMedium
i
7/8/2019StephensInitiated CoverageEqual ➝ Equal Weight$64.00Low
i
7/1/2019CitigroupBoost Price TargetOutperform$68.00 ➝ $75.00High
i
5/7/2019OppenheimerBoost Price TargetOutperform$60.00 ➝ $68.00High
i
5/7/2019Robert W. BairdUpgradeNeutral ➝ Outperform$56.00 ➝ $62.00High
i
2/28/2019CowenSet Price TargetBuy$67.00High
i
Rating by Jeff Osborne at Cowen Inc
2/28/2019JMP SecuritiesLower Price TargetMarket Outperform ➝ Market Outperform$80.00 ➝ $72.00High
i
Rating by Joseph Osha at JMP Securities
2/28/2019Needham & Company LLCReiterated RatingBuy ➝ Buy$70.00High
i
1/23/2019Needham & Company LLCLower Price TargetBuy$75.00Low
i
12/3/2018GuggenheimInitiated CoverageBuy ➝ Buy$70.00High
i
Rating by Michael LaMotte at Guggenheim
11/9/2018CowenReiterated RatingBuy$80.00High
i
Rating by Jeff Osborne at Cowen Inc
11/8/2018ArgusDowngradeBuy ➝ HoldMedium
i
11/6/2018JMP SecuritiesSet Price TargetBuy$80.00High
i
Rating by Joseph Osha at JMP Securities
8/22/2018ArgusUpgradeHold ➝ Buy$72.00Low
i
8/7/2018Robert W. BairdLower Price TargetNeutral ➝ Neutral$75.00 ➝ $68.00High
i
8/7/2018OppenheimerLower Price TargetOutperform ➝ Outperform$76.00 ➝ $72.00High
i
8/6/2018GuggenheimSet Price TargetBuy$73.00Low
i
Rating by Sophie Karp at Guggenheim
8/6/2018CowenSet Price TargetBuy$80.00High
i
Rating by Jeff Osborne at Cowen Inc
6/6/2018Canaccord GenuitySet Price TargetBuy$84.00Low
i
Rating by Chip Moore at Canaccord Genuity
5/16/2018Canaccord GenuityReiterated RatingBuy$84.00Medium
i
Rating by Chip Moore at Canaccord Genuity
4/4/2018Canaccord GenuityReiterated RatingBuy$84.00Low
i
Rating by Chip Moore at Canaccord Genuity
3/22/2018MacquarieInitiated CoverageNeutral ➝ NeutralMedium
i
3/1/2018JMP SecuritiesSet Price TargetMarket Outperform ➝ Buy$108.00Low
i
Rating by Joseph Osha at JMP Securities
3/1/2018CowenUpgradeMarket Perform ➝ Outperform$80.00 ➝ $84.00Medium
i
2/27/2018Canaccord GenuityUpgradeHold ➝ Buy$78.00 ➝ $84.00Medium
i
1/29/2018OppenheimerReiterated RatingBuy$78.00Low
i
Rating by Noah Kaye at Oppenheimer Holdings Inc.
1/2/2018Raymond JamesInitiated CoverageStrong-Buy ➝ Strong-Buy$84.00Medium
i
1/2/2018UBS GroupInitiated CoverageStrong-Buy$84.00Medium
i
12/27/2017Canaccord GenuityReiterated RatingHold$78.00Low
i
11/29/2017ArgusDowngradeBuy ➝ HoldMedium
i
11/3/2017Needham & Company LLCReiterated RatingBuy$84.00N/A
i
10/12/2017JMP SecuritiesSet Price TargetOutperform ➝ Buy$88.00 ➝ $102.00N/A
i
Rating by Joseph Osha at JMP Securities
10/6/2017Canaccord GenuityReiterated RatingHold$78.00N/A
i
9/19/2017Canaccord GenuityDowngradeBuy ➝ Hold$78.00Low
i
9/12/2017Robert W. BairdReiterated RatingHold$77.00Low
i
9/12/2017ArgusReiterated RatingBuy$78.00 ➝ $80.00Low
i
8/4/2017OppenheimerReiterated RatingOutperform$75.00 ➝ $78.00Low
i
Rating by Noah Kaye at Oppenheimer Holdings Inc.
8/3/2017Needham & Company LLCReiterated RatingBuy$74.00 ➝ $84.00Low
i
8/3/2017CowenSet Price TargetHold$60.00 ➝ $74.00High
i
Rating by Jeff Osborne at Cowen Inc
7/26/2017Robert W. BairdDowngradeOutperform ➝ Neutral$73.00 ➝ $77.00Low
i
Rating by Ben Kallo at Robert W. Baird
7/21/2017CowenSet Price TargetHold$60.00Low
i
7/18/2017JMP SecuritiesSet Price TargetBuy$75.00 ➝ $88.00Medium
i
7/14/2017Canaccord GenuityReiterated RatingBuy$78.00Low
i
7/13/2017Robert W. BairdReiterated RatingOutperform$73.00Low
i
Rating by Ben Kallo at Robert W. Baird
6/20/2017GuggenheimInitiated CoverageBuy ➝ Buy$81.00Low
i
5/26/2017Canaccord GenuityReiterated RatingBuy$72.00Low
i
3/9/2017JMP SecuritiesInitiated CoverageMkt Outperform ➝ Outperform$75.00Low
i
3/2/2017Robert W. BairdSet Price TargetBuy$73.00N/A
i
Rating by Ben Kallo at Robert W. Baird
3/1/2017OppenheimerSet Price TargetBuy$70.00N/A
i
Rating by Noah Kaye at Oppenheimer Holdings Inc.
3/1/2017Needham & Company LLCBoost Price TargetBuy ➝ Buy$70.00 ➝ $74.00N/A
i
12/9/2016Robert W. BairdBoost Price TargetBuy$73.00N/A
i
Rating by ben kallo at Robert W. Baird
12/6/2016Needham & Company LLCReiterated RatingBuy$66.00 ➝ $70.00N/A
i
12/5/2016OppenheimerSet Price TargetBuy$60.00 ➝ $70.00N/A
i
Rating by Noah Kaye at Oppenheimer Holdings Inc.
12/5/2016Robert W. BairdReiterated RatingOutperform$62.00N/A
i
Rating by ben kallo at Robert W. Baird
11/19/2016Robert W. BairdReiterated RatingOutperform$62.00N/A
i
Rating by ben kallo at Robert W. Baird
11/14/2016Needham & Company LLCBoost Price TargetBuy$60.00 ➝ $66.00N/A
i
11/4/2016Robert W. BairdReiterated RatingOutperform$62.00N/A
i
Rating by ben kallo at Robert W. Baird
11/3/2016OppenheimerUpgradeMarket Perform ➝ Outperform$60.00N/A
i
11/3/2016UBS GroupUpgradeMarket Perform ➝ OutperformN/A
i
10/26/2016Robert W. BairdReiterated RatingOutperform$56.00 ➝ $62.00N/A
i
Rating by ben kallo at Robert W. Baird
10/3/2016Canaccord GenuityReiterated RatingBuy$57.00 ➝ $61.00N/A
i
Rating by John Quealy at Canaccord Genuity
9/4/2016Robert W. BairdSet Price TargetBuy$56.00N/A
i
Rating by ben kallo at Robert W. Baird
9/4/2016CowenReiterated RatingMarket Perform$45.00 ➝ $50.00N/A
i
9/2/2016Needham & Company LLCBoost Price TargetBuy$46.00 ➝ $60.00N/A
i
9/2/2016Canaccord GenuityReiterated RatingBuy$50.00 ➝ $57.00N/A
i
Rating by John Quealy at Canaccord Genuity
8/13/2016Robert W. BairdReiterated RatingOutperform$47.00N/A
i
Rating by Ben Kallo at Robert W. Baird
5/4/2016Canaccord GenuityReiterated RatingBuyN/A
i
Rating by John Quealy at Canaccord Genuity
(Data available from 4/19/2016 forward)
Itron logo
Itron, Inc. is a technology and services company, which engages in the provision of solutions that measure, manage, and analyze energy and water use. It operates through the following segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment includes hardware products used for measurement, control, or sensing that do not have communications capability embedded for use with its broader Itron systems. The Networked Solutions segment offers a combination of communicating devices, network infrastructure, and associated application software designed and sold as a complete solution for acquiring and transporting robust application-specific data. The Outcomes segment consist of the firm's value-added, enhanced software and services operating segment in which it manage, organize, analyze, and interpret data to improve decision making, maximize operational profitability, drive resource efficiency, and deliver results for consumers, utilities, and smart cities. The company was founded in 1977 and is headquartered in Liberty Lake, WA.
Read More

Today's Range

Now: $88.22
$88.14
$90.72

50 Day Range

MA: $96.65
$83.95
$120.31

52 Week Range

Now: $88.22
$50.87
$122.31

Volume

329,200 shs

Average Volume

604,497 shs

Market Capitalization

$3.98 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.18

Frequently Asked Questions

What sell-side analysts currently cover shares of Itron?

The following sell-side analysts have issued stock ratings on Itron in the last year: Argus, Canaccord Genuity, Cowen Inc, JMP Securities, Johnson Rice, JPMorgan Chase & Co., Morgan Stanley, Oppenheimer Holdings Inc., Piper Sandler, Raymond James, Stephens, Wolfe Research, and Zacks Investment Research.
View the latest analyst ratings for ITRI.

What is the current price target for Itron?

11 Wall Street analysts have set twelve-month price targets for Itron in the last year. Their average twelve-month price target is $97.45, suggesting a possible upside of 10.5%. Argus has the highest price target set, predicting ITRI will reach $140.00 in the next twelve months. Wolfe Research has the lowest price target set, forecasting a price of $56.00 for Itron in the next year.
View the latest price targets for ITRI.

What is the current consensus analyst rating for Itron?

Itron currently has 1 sell rating, 1 hold rating and 10 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe ITRI will outperform the market and that investors should add to their positions of Itron.
View the latest ratings for ITRI.

What other companies compete with Itron?

How do I contact Itron's investor relations team?

Itron's physical mailing address is 2111 N MOLTER ROAD, LIBERTY LAKE WA, 99019. The scientific and technical instruments company's listed phone number is (509) 924-9900 and its investor relations email address is [email protected] The official website for Itron is www.itron.com.